The whistleblower pharmaceutical sales reps in the Procrit case reinstated in a Massachussetts federal court claim that their careers at Johnson & Johnson's Ortho Biotech unit were based mostly on ...

Drug-makers Amgen (AMGN) and Johnson & Johnson (JNJ) are voluntarily recalling two brands of an injectable anemia medication because vials containing the drug may have tiny glass flakes. The drug, ...

(CN) – The Supreme Court on Monday refused to block a lawsuit against a Johnson & Johnson subsidiary by salesmen who accused the company of giving kickbacks to doctors for prescribing its anemia drug ...

Several clinical trials of a widely used anemia drug have been halted in the last few weeks after patients developed a higher-than-expected number of blood clots, according to doctors and Johnson & ...

Johnson & Johnson is trimming its sales force for anemia drug Procrit, a top-seller that has lost market share recently due to increased competition from Amgen’s Aranesp. Ortho Biotech Products, the J ...

Procrit can speed tumor growth and hasten death in cancer patients, and in 2002 the FDA advised doctors to stop prescribing it liberally. A WSJ investigation shows one Florida group continues to ...

Dec. 2, 2005 -- The US Food and Drug Administration (FDA), Amgen Inc, and Ortho Biotech Clinical Affairs, LLC, have notified healthcare professionals via letter regarding revisions to the safety ...

Amgen and Centocor Ortho Biotech announced a voluntary nationwide recall of certain lots of Epogen (epoetin alfa) and Procrit (epoetin alfa) vials that may contain extremely thin glass flakes ...

Please provide your email address to receive an email when new articles are posted on . The FDA today approved epoetin alfa-epbx, the first epoetin alfa biosimilar, for the treatment of anemia caused ...

NEW YORK – Johnson & Johnson (JNJ) has sued Amgen (AMGN), accusing the world's largest biotechnology company of hampering sales of J&J's anemia drug, Procrit (search), by using anti-competitive ...